Age and serum anti-Müllerian hormone levels as predictors of time to return of menses after chemotherapy
Chemotherapeutic agents result in the loss of growing follicles, which can manifest as amenorrhoea. Alkylating chemotherapy (AC) is known to be more gonadotoxic than non-alkylating chemotherapy (NAC). Anti-Müllerian hormone (AMH), an indirect marker of ovarian reserve, and age have been investigated...
Saved in:
Main Authors: | Madhavi-Priya Singh, Rashi Kalra, Franca Agresta, Alec Leos, Samith Minu Alwis, Alex Polyakov, Genia Rozen, Kate Stern |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2025-01-01
|
Series: | Reproduction and Fertility |
Subjects: | |
Online Access: | https://raf.bioscientifica.com/view/journals/raf/6/1/RAF-24-0046.xml |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review
by: Duru Shah, et al.
Published: (2024-01-01) -
Co-occurrence of a Mullerian anomaly and Kallmann syndrome: A case report
by: Lea C. George, et al.
Published: (2025-03-01) -
Correlation of Anti-Müllerian Hormone with Polycystic Ovarian Disease and its Relation with Age
by: Sara Omer Muhammed, et al.
Published: (2019-08-01) -
Fertility Preservation in Female Patients with Cancer Part II: Royan Institute Clinical Practice Guideline for Girls and Women with Cancer; A Review Study
by: Azar Yahyaei, et al.
Published: (2025-01-01) -
Is There a Relationship between Serum Anti-Mullerian Hormone Levels and Abortion Rates in Patients Who Received In vitro Fertilisation-Embryo Transfer Cycles?
by: Pinar Karacin, et al.
Published: (2023-01-01)